CN
|
EN
Home
Introduction to the 2023 CBIIC
Main Conference
Previous Speakers
News
Organizations
Service
Transportation & Accommodation
Guidance
Contact us
Previous Review
Home
About CBIIC
Agenda
Previous Speakers
News
Expert
Organizations
Service
Transportation & Accommodation
Guidance
Contact us
Previous Review
Business Matching Service
Register
Roadshow Application
Onsite Participant Registration
CN
EN
Non-Listed Company Roadshow
Agendas
9:00 - 12:20
非上市公司路演专场
Non-Listed Company Roadshow
Moderator
汤泰萌 , 西南证券股份有限公司医药行业高级分析师
TANG Taimeng , Healthcare Senior Analysist of Southwest Securities
9:00 - 9:20
项目1
Project 1
ABM1310-新型透脑BRAF抑制剂在成人实体瘤中的多中心开放标签中美I期临床试验
A Phase 1 Multicenter, Open-Label Study of A New BRAF Inhibitor ABM-1310 in Adult Patients With BRAF-Mutated Solid Tumors
陈晨 璧辰医药创始人/董事长/CEO
CHEN Chen , Founder/Chairperson/CEO, ABM Therapeutics
9:20 - 9:40
项目2
Project 2
新一代微生物疗法开发平台
Innovative Microbial Therapeutics Development Platform
蒋先芝 慕恩(广州)生物科技有限公司创始人、总经理
JIANG Xianzhi , Founder & CEO, MoonBiotech
9:40 - 10:00
项目3
Project 3
基于长效重组人血清白蛋白融合蛋白平台的生物创新药
Bioinnovative Drugs Based on Long-Term Recombinant Human Serum Albumin Fusion Protein Platform
杨京生 华通福源生物技术(北京)股份有限公司总经理
YANG Jingsheng , CEO, Huatong FortuneRock (China) Co., Ltd.
10:00 - 10:20
项目4
Project 4
原创广谱抗炎药——伊匹乌肽
Original Broad-Spectrum Anti-Inflammatory Drug-Epivotide
夏献民 武汉益承生物科技有限公司总经理
XIA Xianmin , General Manager, Wuhan Yicheng Biotechnology Co., Ltd.
10:20 - 10:40
项目5
Project 5
甫康药业;差异化临床策略+创新合作商业策略,打造确定性更强的创新药企业成长路径
Convalife; Success in Clinical, Success in Sales
沈孝坤 甫康(上海)健康科技有限责任公司首席执行官
Steve SHEN , CEO, Convalife Pharmaceuticals Co., Ltd.
10:40 - 11:00
项目6
Project 6
星曜坤泽——致力于肝病领域未满足的临床需求
Hepa Thera - Committed to the Innovative Treatment of Unmet Clinical Needs in the Field of Liver Disease
马彦琴 苏州星曜坤泽生物制药有限公司执行总裁
Sophy MA , CEO, Suzhou Hepa Thera Biopharmaceutical Co., Ltd.
11:00 - 11:20
项目7
Project 7
靶向离子通道的治疗神经系统疾病创新药物
Innovative Drugs Targeting Ion Channels for Treating Neurological Diseases
毛声俊 成都新睿泰康科技有限公司总经理
MAO Shengjun , General Manager, Chengdu New Insights and Health Science Technology Co., Ltd.
11:20 - 11:40
项目8
Project 8
应用合成生物学开发口服生物创新药
Development of Oral Biological Medicines Using Synthetic Biology
高世宏 武汉康复得生物科技股份有限公司副总经理
GAO Shihong , Vice General Manager, Wuhan Kangfude Biotechnology Co., Ltd.
11:40 - 12:00
项目9
Project 9
博奥明赛——专注于全人源纳米双抗研发的临床公司
Biomissile-A Clinical Stage Company Focusing on Developing Fully Human Domain Antibody (UDAB
TM
) and Multi-specific Antibody (UDAB-M
TM
)
王敏 博奥明赛生物制药有限公司商务发展副总裁
Winnie WANG , BD VP, Biomissile Pharmaceuticals Co., Ltd.
12:00 - 12:20
项目10
Project10
聚焦解除肿瘤免疫微环境中抑制因子,实现“冷肿瘤”向“热肿瘤”转换
Turning “Cold” Tumors “Hot” by Removing Immune Suppressive Factors in the TME
秦续科 科望医药首席医学官
Steve CHIN , CMO, Elpiscience Biopharma, Ltd.